# RIOCIGUAT
> **ANDA211135** · Abbreviated New Drug Application (Generic) · Sponsor: MSN · Approved 2022-09-01
## Drug
- **FDA Application Number:** ANDA211135
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RIOCIGUAT
- **Generic name:** Riociguat
- **Active ingredients:** RIOCIGUAT
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MSN
- **First approval:** 2022-09-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211135)
---
*MORVS · CC0 1.0*